
Sign up to save your podcasts
Or
Prior randomized trials of convalescent plasma in COVID-19 have had disappointing results. However, these trials included patients with severe illness who were many days (if not weeks) into the course of their illness. To date, it was hypothesized, but unknown, that the benefit would be in patients very early in the course of their illness. We cover an RCT by Libster et al in NEJM on convalescent plasma in older patients with mild COVID-19.
Show notes/references: FOAMcast.org
Thanks for listening!
Lauren Westafer and Jeremy Faust
4.7
274274 ratings
Prior randomized trials of convalescent plasma in COVID-19 have had disappointing results. However, these trials included patients with severe illness who were many days (if not weeks) into the course of their illness. To date, it was hypothesized, but unknown, that the benefit would be in patients very early in the course of their illness. We cover an RCT by Libster et al in NEJM on convalescent plasma in older patients with mild COVID-19.
Show notes/references: FOAMcast.org
Thanks for listening!
Lauren Westafer and Jeremy Faust
1,871 Listeners
547 Listeners
500 Listeners
264 Listeners
383 Listeners
100 Listeners
804 Listeners
3,339 Listeners
260 Listeners
263 Listeners
1,149 Listeners
249 Listeners
372 Listeners
315 Listeners
234 Listeners